Gary Gershony

About Gary Gershony

Dr. Gershony graduated from University of Toronto Medical School where he also completed his training in general cardiology. He subsequently completed a fellowship in interventional cardiology at Emory University under Andreas Grüntzig, the inventor of angioplasty. From 19••••97 he was Director of the Cardiac Cath Lab and Interventional Cardiology at UC Davis. Since he has practiced interventional cardiology at John Muir Cardiovascular Institute in the Bay Area where he was Director of Cardiovascular Research, Education and Technology, and established a successful TAVR program starting in 2011. Dr. Gershony is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. He has authored over 100 manuscripts and abstracts in the field of cardiology and is a regularly invited faculty to the preeminent U.S. and international interventional cardiology conferences. Dr. Gershony was the Founder of Vascular Solutions (VASC), which had a successful IPO in and for which he served as CMO and a member of the BOD from 19••••02. He was the principal inventor of the Duett™ Vascular Sealing Device. Dr. Gershony was also the Co-Founder and CMO of AngioScore, which developed novel scoring balloon catheters for coronary and peripheral angioplasty procedures. He was a member of the senior management team from 2003 until AngioScore’s successful acquisition by Spectranetics (SPNC) in 2014. Dr. Gershony has served on the adjunct faculty of the Stanford Biodesign Innovation Program. He is the author of 11 issued medical device patents. He has been a member of the scientific advisory board or a consultant to numerous medical device companies and venture capitalists in the Bay Area and elsewhere.Dr. Gershony is a founding General Partner of BayMed Venture Partners, a venture capital firm based in San Francisco, which is focused on maturing early-stage Medical Device and Digital Health companies located in North America and Israel. He is currently a Board member of ValFix Medical, Crystalline Medical, RAM Medical, Deep Blue Medical Advances and Trisol Medical, and a Scientific Advisory Board member of AtaCor Medical and Append Medical. He is also a frequent speaker or panelist at early-stage MedTech and Digital Health investor conferences.

Experience

1. Director Board of Directors

   Valfix Medical

   Oct 2019 — Present

Education

• University of Toronto

  General Cardiology Fellowship

• Stanford University Graduate School of Business

  FANFE - Executive Program

• University of Toronto

  Doctor of Medicine - MD, Medicine

• University of Toronto

  Internal Medicine Residency

• Emory University School of Medicine

  Interventional Cardiology Fellowship

Skills

• Product Development
• Market Development
• Cardiology
• Surgery
• Vascular
• Capital Equipment
• U.s. Food and Drug Administration (Fda)
• Product Launch
• Medical Devices
• Healthcare
• Hospitals